MENU
+Compare
RVMD
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$42.93
Change
-$2.23 (-4.94%)
Capitalization
8.35B

RVMD Revolution Medicines Forecast, Technical & Fundamental Analysis

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for RVMD with price predictions
Dec 17, 2024

RVMD's Indicator enters downward trend

The Aroon Indicator for RVMD entered a downward trend on December 17, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 161 similar instances where the Aroon Indicator formed such a pattern. In of the 161 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 02, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RVMD as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RVMD turned negative on November 15, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

RVMD moved below its 50-day moving average on December 03, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RVMD crossed bearishly below the 50-day moving average on December 10, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RVMD advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

RVMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RVMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.274) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). RVMD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). RVMD's P/S Ratio (10000.000) is very high in comparison to the industry average of (260.687).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVMD is expected to report earnings to rise 5.77% to -99 cents per share on March 03

Revolution Medicines RVMD Stock Earnings Reports
Q4'24
Est.
$-0.99
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.05
Q4'23
Missed
by $0.29
The last earnings report on November 06 showed earnings per share of -93 cents, missing the estimate of -89 cents. With 495.77K shares outstanding, the current market capitalization sits at 8.35B.
A.I. Advisor
published General Information

General Information

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UVIX3.420.14
+4.43%
2x Long VIX Futures ETF
XBJA28.750.05
+0.16%
Innovator US Eq Acclrtd 9 Bffr ETF Jan
PSCX27.64-0.02
-0.05%
Pacer Swan SOS Conservative (Jan) ETF
PDEC38.87-0.08
-0.21%
Innovator U.S. Eq Power Buffer ETF - Dec
IWY243.77-0.94
-0.38%
iShares Russell Top 200 Growth ETF

RVMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with KYMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+1.01%
KYMR - RVMD
43%
Loosely correlated
-1.76%
IDYA - RVMD
43%
Loosely correlated
+1.07%
ORMP - RVMD
42%
Loosely correlated
-1.67%
PGEN - RVMD
41%
Loosely correlated
+2.46%
RYTM - RVMD
41%
Loosely correlated
+2.81%
More